Nexvet Biopharma plc 4
4 · Nexvet Biopharma plc · Filed Oct 4, 2016
Insider Transaction Report
Form 4
Hanna Ashraf
Director
Transactions
- Exercise/Conversion
Restricted Share Units
2016-09-30−500→ 1,500 totalExercise: $0.13Exp: 2019-07-01→ Ordinary Shares (500 underlying) - Exercise/Conversion
Ordinary Shares
2016-09-30$0.13/sh+500$63→ 10,920 total
Holdings
- 1,500(indirect: By Trust)
Ordinary Shares
Footnotes (1)
- [F1]500 of the Restricted Share Units vested and became convertible on 9/30/16, and 500 Restricted Share Units shall vest and become convertible on each of 12/31/16, 3/31/17 and 6/30/17, in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting.